智通财经APP获悉，美银证券发布研报称，京东健康(06618)第三季业绩胜预期，收入同比增长加速至29%，对比上半年为25%; 经调整经营利润维持同比60%快速增长，经调整经营利润率扩张至8%的历史新高。 至于第四季，该行保守维持原有预期，等待流感季节进一步明朗化。目标价由71港元升至75港元，重申“买入”评级。
考虑到第三季业绩胜预期，该行将2025年收入增长预测由22%上调至23%，并将经调整净利润预测上调10%至62亿元人民币。针对2026年，虽然公司未有目标指引，该行仍对其增长保持乐观，且不认为O2O投资会大幅增加。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.